Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 4
2006 2
2007 4
2009 1
2010 4
2011 6
2012 2
2013 10
2014 5
2015 6
2016 8
2017 15
2018 7
2019 11
2020 8
2021 13
2022 6
2023 8
2024 2
2025 7
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Ra E, Ito Y, Kawano K, Iwase T, Kaneko H, Ueno S, Yasuda S, Kataoka K, Terasaki H. Ra E, et al. Among authors: iwase t. Am J Ophthalmol. 2017 Aug;180:178-179. doi: 10.1016/j.ajo.2017.05.012. Epub 2017 May 31. Am J Ophthalmol. 2017. PMID: 28577756 No abstract available.
Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyes.
Murao F, Yanai R, Kusuhara S, Abe Y, Shimura M, Ohara H, Terasaki H, Sugimoto M, Matsubara H, Hirano Y, Kinoshita T, Tsujinaka H, Seki K, Iwase T, Mitamura Y; J-CREST. Murao F, et al. Among authors: iwase t. Sci Rep. 2025 Oct 21;15(1):36628. doi: 10.1038/s41598-025-20300-6. Sci Rep. 2025. PMID: 41120399 Free PMC article.
ALTERATION OF TREATMENT CHOICES AND THE VISUAL PROGNOSIS FOR DIABETIC MACULAR EDEMA IN THE ERA OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR DRUGS: Analysis of the STREAT-DME 2 Study.
Shimura M, Hirano T, Tsuiki E, Takamura Y, Morizane Y, Akiyama K, Yamamoto K, Hikichi T, Koto T, Kinoshita T, Kusuhara S, Yoshida S, Sakamoto SI, Kimura K, Sugimoto M, Kida T, Mitamura Y, Takatsuna Y, Washio N, Osaka R, Ueda T, Minamoto A, Kogo J, Okamoto F, Enaida H, Sakanishi Y, Nagaoka T, Gomi F, Sasaki M, Terasaki H, Iwase T, Tatsumi T, Nishi K, Shinoda K, Ueda S, Ueda-Consolvo T, Nakashizuka H, Murata T, Kitano S, Sakamoto T; J-CREST STREAT-DME 2 Study Group. Shimura M, et al. Among authors: iwase t. Retina. 2025 Feb 1;45(2):335-344. doi: 10.1097/IAE.0000000000004301. Retina. 2025. PMID: 39423137 Free PMC article.
Efficacy of vitrectomy combined with and without cataract surgery for diabetic macular edema: one-year follow-up multi-center study in Japan.
Yamada Y, Takamura Y, Saito K, Minamoto A, Ishigooka G, Koto T, Nakano Y, Tsuiki E, Terasaki H, Shimizu M, Kimura M, Mitamura Y, Sekine R, Mizusawa Y, Hirano T, Oyama T, Iwase T, Higashijima F, Matsubara H, Inatani M; J.-CREST (Japan Clinical REtina STudy group). Yamada Y, et al. Among authors: iwase t. Graefes Arch Clin Exp Ophthalmol. 2025 Sep;263(9):2651-2662. doi: 10.1007/s00417-025-06845-2. Epub 2025 May 6. Graefes Arch Clin Exp Ophthalmol. 2025. PMID: 40327087 Free PMC article.
6-month outcomes of intravitreal faricimab injection for neovascular age-related macular degeneration and their relationships with clinical findings: a multicentre cohort study from the J-CREST.
Yanai R, Murao F, Miki A, Terasaki H, Chujo S, Sakaeda Y, Seki K, Ishigouoka G, Iwase T, Ohara H, Tsujinaka H, Fukuyama H, Abe Y, Nishi Y, Kinoshita T, Kondo M, Sakamoto T, Mitamura Y; Japanese Clinical Retinal Study (J-CREST) Group. Yanai R, et al. Among authors: iwase t. BMJ Open Ophthalmol. 2025 Sep 25;10(1):e002415. doi: 10.1136/bmjophth-2025-002415. BMJ Open Ophthalmol. 2025. PMID: 40998549 Free PMC article.
Relationship between tinnitus and olfactory dysfunction: audiovisual, olfactory, and medical examinations.
Katayama N, Yoshida T, Nakashima T, Ito Y, Teranishi M, Iwase T, Sugiura S, Goto K, Uchida Y, Taki Y, Nakada T, Tada A, Suzuki H, Nakano Y, Shimono M, Saji N, Kogure A, Shimizu E, Sone M, Hamajima N. Katayama N, et al. Among authors: iwase t. Front Public Health. 2023 Apr 20;11:1124404. doi: 10.3389/fpubh.2023.1124404. eCollection 2023. Front Public Health. 2023. PMID: 37151589 Free PMC article.
PULSAR: Clinical Outcomes of Aflibercept 8 mg with Extended Dosing and 2 mg in Neovascular Age-Related Macular Degeneration in Subgroups Defined by Baseline Characteristics.
Gale RP, Loewenstein A, Zhang X, Leal S, Machewitz T, Sivaprasad S, Wong DT, Zeitz O, Korobelnik JF; PULSAR study investigators. Gale RP, et al. Ophthalmol Retina. 2026 Mar 18:S2468-6530(26)00109-0. doi: 10.1016/j.oret.2026.02.020. Online ahead of print. Ophthalmol Retina. 2026. PMID: 41861959
124 results